Drug Profile
ELL 12
Alternative Names: edelfosine-liposomal; liposomal edelfosine; TLC ELL 12Latest Information Update: 02 May 2007
Price :
$50
*
At a glance
- Originator Elan Corporation
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer